Vericel (VCEL) Inventory Average (2014 - 2026)
Vericel (VCEL) posted Inventory Average of $18.4 million for Q2 2026, up 2.29% sequentially from $18.0 million in Q1 2026, and up 8.24% YoY from $17.0 million in Q2 2025.
Analysis
Vericel (VCEL) Inventory Average (2014 - 2026) Analysis & Trends
Vericel has reported Inventory Average for 13 years, with the latest figure at $18.4 million in Q2 2026.
- Quarterly Inventory Average rose 8.24% year-over-year to $18.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.4 million (up 8.24% YoY) and the FY2025 annual result came in at $17.5 million, up 14.68% from the prior year.
- Inventory Average improved to $18.4 million in Q2 2026 per VCEL's latest filing, from $18.0 million in the prior quarter.
- Over five years, Inventory Average peaked at $18.4 million in Q2 2026 and troughed at $12.9 million in Q4 2023.
- A 5-year average of $15.7 million and a median of $16.0 million in 2022 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2023: Inventory Average surged 41.1% in 2022, then declined 21.42% in 2023.
- Over 5 years, Inventory Average stood at $16.4 million in 2022, then decreased by 21.42% to $12.9 million in 2023, then advanced by 28.87% to $16.6 million in 2024, then climbed by 7.81% to $17.9 million in 2025, then rose by 2.85% to $18.4 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $18.4 million, $18.0 million, and $17.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 18.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.37 Mn |
| Mar 31, 2026 | 17.96 Mn |
| Dec 31, 2025 | 17.86 Mn |
| Sep 30, 2025 | 17.49 Mn |
| Jun 30, 2025 | 16.97 Mn |
| Mar 31, 2025 | 17.24 Mn |
| Dec 31, 2024 | 16.56 Mn |
| Sep 30, 2024 | 15.32 Mn |
| Jun 30, 2024 | 14.22 Mn |
| Mar 31, 2024 | 13.32 Mn |
| Dec 31, 2023 | 12.85 Mn |
| Sep 30, 2023 | 13.25 Mn |
| Jun 30, 2023 | 14.63 Mn |
| Mar 31, 2023 | 15.68 Mn |
| Dec 31, 2022 | 16.36 Mn |
| Sep 30, 2022 | 16.33 Mn |
| Jun 30, 2022 | 15.16 Mn |
| Mar 31, 2022 | 13.88 Mn |
| Dec 31, 2021 | 13.22 Mn |
| Sep 30, 2021 | 13.01 Mn |